Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma

    Tag: pharma

    You Searched For "pharma"
    GSK gets USFDA nod for Benlysta to treat pediatric patients with lupus

    GSK gets USFDA nod for Benlysta to treat pediatric patients with lupus

    Medical Dialogues Bureau30 April 2019 9:15 AM IST
    New Delhi: GlaxoSmithKline (GSK) has won the US Food and Drug Administration's (USFDA) approval for its Benlysta (belimumab) intravenous (IV) infusion...
    Pfizer gets CHMP opinion for Talzenna for patients with metastatic breast cancer

    Pfizer gets CHMP opinion for Talzenna for patients with metastatic breast cancer

    Farhat Nasim29 April 2019 9:35 AM IST
    The positive CHMP opinion of TALZENNA follows the medicine's approval by the U.S. Food and Drug Administration (FDA) in October 2018.New Delhi:...
    Roche withdraws refiling of Premerger Notification, Report Form under the HSR Act

    Roche withdraws refiling of Premerger Notification, Report Form under the HSR Act

    Farhat Nasim28 April 2019 9:45 AM IST
    Roche has elected to withdraw and refile the Premerger Notification and Report Form under the HSR Act.New Delhi: Roche and Spark Therapeutics, Inc....
    Sun Pharma gets 11 USFDA observations for Dadra plant, BSE asks for response: Report

    Sun Pharma gets 11 USFDA observations for Dadra plant, BSE asks for response: Report

    Farhat Nasim26 April 2019 2:20 PM IST
    New Delhi: Sun Pharmaceutical (Sun Pharma) Industries Ltd's Dadra plant has reportedly received 11 observations, "serious" in nature from the U.S....
    Zydus Cadila gets final USFDA nod for Leflunomide tablets to treat arthritis

    Zydus Cadila gets final USFDA nod for Leflunomide tablets to treat arthritis

    Farhat Nasim26 April 2019 12:49 PM IST
    Leflunomide tablet is used to treat rheumatoid arthritis, a condition affecting multiple small and large joints of the body.New Delhi: Drug firm Zydus...
    Indoco Remedies: USFDA retains OAI status for Goa plant

    Indoco Remedies: USFDA retains OAI status for Goa plant

    Farhat Nasim25 April 2019 9:50 AM IST
    Indoco Remedies' spokesperson said that the move is likely to withhold approval of pending abbreviated new drug applications (ANDAs) from Goa...
    Rochester Drug Cooperative fined $20 million in criminal case against drug distributor over opioids

    Rochester Drug Cooperative fined $20 million in criminal case against drug distributor over opioids

    Medical Dialogues Bureau24 April 2019 9:00 AM IST
    The company where the executives worked, Rochester Drug Cooperative (RDC), is one of the country's largest distributors of prescription opioids. It...
    Mylan, TB Alliance to commercialize Pretomanid to treat TB

    Mylan, TB Alliance to commercialize Pretomanid to treat TB

    Farhat Nasim23 April 2019 10:00 AM IST
    TB Alliance began preclinical development of pretomanid in 2002, and it has since studied pretomanid in 20 clinical trials alone or in combination...
    Eli Lilly to sell legacy antibiotics brands Ceclor, Vancocin, China facility to Eddingpharm

    Eli Lilly to sell legacy antibiotics brands Ceclor, Vancocin, China facility to Eddingpharm

    Farhat Nasim23 April 2019 9:45 AM IST
    INDIANAPOLIS: Eli Lilly and Company today announced that it has entered into an agreement to sell the rights in China for two legacy Lilly antibiotic...
    Cipla appoints Dr Raju Mistry as Global Chief People Officer

    Cipla appoints Dr Raju Mistry as Global Chief People Officer

    Medical Dialogues Bureau23 April 2019 9:15 AM IST
    In her role at Cipla, Raju Mistry will oversee Human Resources, and Administration and Facilities Management. She will be a member of the Management...
    Patent Infringement: Cadila Healthcare, two others prohibited from launching Linagliptin Metformin Hydrochloride tablets

    Patent Infringement: Cadila Healthcare, two others prohibited from launching Linagliptin Metformin Hydrochloride tablets

    Meghna A Singhania22 April 2019 2:07 PM IST
    AHMEDABAD: In a major setback, three Gujarat based pharmaceutical companies including Cadila Healthcare, West Coast Pharmaceutical Works Ltd and Maan...
    Drugs registered on SUGAM portal to be exempted from obtaining licence for purpose of examination, test, analysis

    Drugs registered on SUGAM portal to be exempted from obtaining licence for purpose of examination, test, analysis

    Meghna A Singhania21 April 2019 2:26 PM IST
    The exemption from obtaining a licence for Form 29 is subject to the condition that the information about the manufacturing of approved drugs for...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok